Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic Therapy for Migraine.

Shazia Afridi1, Holger Kaube

  • 1Headache Group, Institute of Neurology, Queen Square, London WC1N 3BG, UK. h.kaube@ion.ucl.ac.uk

Current Treatment Options in Neurology
|October 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine: A Randomized, Double-Blind, Sham-Controlled Trial.

Neurology·2025
Same author

<i>NF2</i>-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study.

Journal of medical genetics·2024
Same author

Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression.

Neuro-oncology advances·2023
Same author

Reliability of functional outcome measures in adults with neurofibromatosis 2.

SAGE open medicine·2022
Same author

Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi survey.

European journal of pain (London, England)·2021
Same author

Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD.

Cancer genetics·2021
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Migraine, a condition with ancient roots, remains underdiagnosed. New preventative medications offer hope for many sufferers, complementing existing treatments like triptans.

Area of Science:

  • Neurology
  • Pain Medicine
  • Headache Disorders

Background:

  • Migraine descriptions date back to 3000 BC, with the term 'hemicrania' introduced by Galen around 200 AD.
  • Despite its long history, migraine remains a prevalent neurological condition that is frequently underdiagnosed and undertreated.
  • While effective abortive treatments like triptans have improved management, a significant number of patients require additional therapeutic strategies.

Purpose of the Study:

  • To review the historical context and current challenges in migraine diagnosis and treatment.
  • To highlight the unmet needs in migraine management.
  • To emphasize the potential of preventative therapies in transforming patient outcomes.

Main Methods:

  • Literature review of historical texts and modern medical publications on migraine.

Related Experiment Videos

  • Analysis of diagnostic trends and treatment efficacy data.
  • Evaluation of the role of preventative medications in current clinical practice.

    • Main Results:

    • Historical records indicate a long-standing recognition of migraine-like symptoms.
    • Current data reveal persistent issues with underdiagnosis and undertreatment globally.
    • Preventative treatments show promise for a substantial patient subset inadequately managed by abortive therapies alone.

    Conclusions:

    • Migraine management requires a multifaceted approach, addressing both acute attacks and chronic frequency.
    • Preventative therapies represent a critical advancement, offering improved quality of life for many individuals with chronic migraine.
    • Further research and clinical attention are necessary to optimize diagnosis and treatment strategies for all migraineurs.